Relative importance of emergency medical system transport and the prehospital electrocardiogram on reducing hospital time delay to therapy for acute myocardial infarction: A preliminary report from the Cincinnati Heart Project

https://doi.org/10.1016/0002-8703(92)90684-NGet rights and content

Abstract

Substantial time delays from symptom onset to diagnosis and treatment of patients with acute myocardial infarction have been demonstrated. To determine the relative importance of prehospital mode of patient transport and the relative impact of emergency medical system transport with or without a prehospital cellular electrocardiogram (ECG) on hospital time delays to initiation of thrombolytic therapy, four prospective parallel groups of patients with acute myocardial infarction were evaluated. The median hospital time delay to treatment median (twenty-fifth and seventy-fifth percentiles) was 64 minutes (46 and 87 minutes, respectively, for twenty-fifth and seventy-fifth percentiles) for patients transported by private automobile (“walk-in”); 55 minutes (45 and 68 minutes, respectively) for patients transported by local ambulance; 50 minutes (38 and 81 minutes, respectively) for patients transported by the emergency medical system without a prehospital ECG; and 30 minutes (27 and minutes, respectively) for patients transported by the emergency medical system who had a 12-lead ECG transmitted from the field. Patients transported by the emergency medical system were randomized to receive cellular telephone transmission of a prehospital 12-lead ECG. Specialized emergency medical system transport alone did not facilitate in-hospital initiation of thrombolytic therapy in patients with acute myocardial infarction when compared with those brought by local ambulance or by private automobile. A significant reduction in hospital time delay to treatment was observed only in patients transported by the emergency medical system who had cellular transmission of a prehospital 12-lead ECG from the field.

References (26)

  • GISSI

    Long-term effects of intravenous thrombolysis in acute myocardial infarction: Final report of the GISSI study

    Lancet

    (1987)
  • GISSI

    Effectiveness of intravenous thrombolytic therapy in acute myocardial infarction

    Lancet

    (1986)
  • Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2

    Lancet

    (1988)
  • Cited by (148)

    • False Activations for ST-Segment Elevation Myocardial Infarction

      2016, Interventional Cardiology Clinics
      Citation Excerpt :

      It is desirable to maximize the rate of appropriate CCL activations following the PH-ECG.15 Time to revascularization can be substantially reduced with a PH-ECG–based CCL activation strategy.16,17 However, emergent coronary angiography ± PPCI is a precious resource, particularly after working hours and on weekends when CCL staff are not on site.

    • Time to Treatment: Focus on Transfer in ST-Elevation Myocardial Infarction

      2016, Interventional Cardiology Clinics
      Citation Excerpt :

      The use of the prehospital ECG was strongly recommended because it significantly reduces the time to reperfusion. It gives the opportunity to make the diagnosis in the prehospital setting and alert the receiving hospital of an incoming STEMI patient.25–28 Diagnostic quality 12-lead ECGs can be obtained in the majority of patients.31

    • Systematic review and meta-analysis of the benefits of out-of-hospital 12-lead ECG and advance notification in ST-segment elevation myocardial infarction patients

      2014, Annals of Emergency Medicine
      Citation Excerpt :

      After duplicates were removed, there were 1,338 unique citations. The full texts of 68 citations were screened,11,12,16,17,24-87 with 16 studies included in the review12,16,74-87 and 52 studies excluded.11,17,24-73 Two studies reported outcomes separately for patients who received primary percutaneous coronary intervention and fibrinolysis.16,75

    View all citing articles on Scopus

    This study was supported part by research grants from Genentech, Inc., South San Francisco, Calif., and from The Penn Central Corporation, Cincinnati, Ohio.

    Coinvestigators listed in Appendix.

    View full text